Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applitech Biological Technology is a leading Chinese high-tech enterprise specializing in the design and manufacture of advanced bioreactor systems and related process analytics equipment serving the global biotechnology and pharmaceutical industries. The company’s product portfolio spans R&D through commercial-scale cGMP applications supporting antibody therapeutics development/manufacture as well as vaccine/cell/gene/stem cell therapies. With headquarters in Guangzhou since its founding in 2009—and branch offices throughout major Chinese cities—Applitech has established itself as a key enabler of modern biologics process development both domestically and increasingly across Asia-Pacific through strategic partnerships such as that with Singapore-based InnoCellular Tech Pte Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applitech Biological Technology.